Detalhe da pesquisa
1.
Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2.
Front Immunol
; 15: 1353353, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571939
2.
Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines.
Virology
; 585: 179-185, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356253
3.
Substitutions in SARS-CoV-2 Mpro Selected by Protease Inhibitor Boceprevir Confer Resistance to Nirmatrelvir.
Viruses
; 15(9)2023 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766376
4.
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination.
EBioMedicine
; 89: 104475, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870117
5.
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
Lancet Microbe
; 4(3): e140-e148, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681093
6.
Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system.
Sci Adv
; 8(51): eadd7197, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36542720